Iodide

Iodide

SCHEMBL6175053

I.I.Nc1ccc(-c2csc(N)n2)cc1

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.68
RAB9A P51151 7/20 0.68
NPC1 O15118 6/20 0.68
MAPT P10636 6/20 0.68
LTA4H P09960 6/20 0.68
SMN1; SMN2 Q16637 5/20 0.68
KDM4E B2RXH2 3/20 0.68
NFKB1 P19838 2/20 0.68
NFKB2 Q00653 2/20 0.68
RELA Q04206 2/20 0.68
MEN1 O00255 2/20 0.68
KMT2A Q03164 2/20 0.68
LMNA P02545 1/20 0.68
MKNK1 Q9BUB5 1/20 0.68
MKNK2 Q9HBH9 1/20 0.68
ALOX5 P09917 1/20 0.68
CYP3A4 P08684 1/20 0.62
POLB P06746 1/20 0.61
AR P10275 1/20 0.56
GFER P55789 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL172279 0.98 ALDH1A1 (0.70) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL1771825 0.91 ALDH1A1 (0.79) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL23610361 0.89 ALDH1A1 (0.83) ALDH1A1RAB9ANPC1MAPTLTA4H
Iodide SCHEMBL6959702 0.83 ALDH1A1 (0.96) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL11152023 0.83 RAB9A (0.58) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL15829173 0.81 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL1802130 0.81 ALDH1A1 (0.66) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL5321407 0.81 LTA4H (1.00) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL128793 0.81 ALDH1A1 (1.00) ALDH1A1RAB9ANPC1MAPTLTA4H
SCHEMBL428793 0.81 RAB9A (0.96) ALDH1A1RAB9ANPC1MAPTLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949543-B2 Amide derivative YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 2005-09-27 US disclosed
EP-1340750-B1 AMIDE DERIVATIVES YAMANOUCHI PHARMA CO LTD (JP) 2005-08-17 EP disclosed
US-20040034232-A1 Amide derivative ASTELLAS PHARMA INC. (JP) 2004-02-19 US disclosed
EP-1340750-A1 AMIDE DERIVATIVES YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034232-A1 Amide derivative HDAC2, ZC3HAV1, HDAC4 ALDH1A1 3774/4885RAB9A 1475/4885NPC1 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.